For example, in S3, AZGP1, up-regulated, is described in the literature as stimulating lipid degradation in adipocytes and causing the extensive fat losses associated with some advanced cancers and antigen processing and presentation of endogenous peptide antigen via MHC class Ib [54]. The gene discussed is AZGP1; the disease is cancer.